<DOC>
	<DOCNO>NCT03091348</DOCNO>
	<brief_summary>In randomize , cross‐over study 20 subject undergo testosterone ( T ) therapy treatment T deficiency receive subcutaneous testosterone therapy intramuscular testosterone therapy . One group receive SQ injection follow IM injection one group receive IM injection follow SQ injection . The primary objective study measure testosterone concentration men two treatment route determine significant difference due mode administration . Endpoints include total serum testosterone calculate free testosterone . A questionnaire also administer assess overall patient experience route administration .</brief_summary>
	<brief_title>Subcutaneous vs. Intramuscular Testosterone</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Eunuchism</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Ability read , write , understand English Age great equal 18 Diagnosed testosterone deficiency Pre‐enrollment testosterone concentration le 350 ng/dL Planning initiate testosterone treatment MHB Willing follow MHB least one month Willing provide inform consent study Previous exposure exogenous T , clomiphene citrate , Selective Estrogen Receptor Modulators , unless therapy least 12 week American Urological Association Prostate Symptom score 15 great significant prostatic symptom History carcinoma , tumor induration prostate male mammary gland , include suspicion thereof Pre‐enrollment serum PSA 4 ng/ml Serious psychiatric disease uncontrolled medical illness , suspect history clinical examination Used sex hormone steroidal anabolic drug supplement within 28 day pre‐enrollment testosterone collection time throughout study Incapable give informed consent comply protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>